Loading…
Loading…
how much visibility and confidence do you have in hitting the implied $410 million of data revenue guidance
is there anything in terms of either the recent Gilead or Merck deal that you would call out in terms of size or scope
could you comment on why you're leaning into agent development and safety given how historically reluctant to change that segment of the market has been